Inventor
BAMDAD CYNTHIA
US26 patents
⚠️ This page may combine multiple inventors who share the name “BAMDAD CYNTHIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MINERVA BIOTECHNOLOGIES CORP
25 patentsUS11976132B2May 7, 2024
Diagnostic methods using anti-MUC1* antibodies
MINERVA BIOTECHNOLOGIES CORP5 citations85
US11746159B2Sep 5, 2023
Humanized anti-MUC1* antibodies
MINERVA BIOTECHNOLOGIES CORP8 citations84
US11591565B2Feb 28, 2023
Media for stem cell proliferation and induction
MINERVA BIOTECHNOLOGIES CORP5 citations84
US9932407B2Apr 3, 2018
Stem cell enhancing therapeutics
MINERVA BIOTECHNOLOGIES CORP8 citations84
US12195728B2Jan 14, 2025
Method for making pluripotent stem cells
MINERVA BIOTECHNOLOGIES CORP1 citations74
US12049618B2Jul 30, 2024
Method for making pluripotent stem cells
MINERVA BIOTECHNOLOGIES CORP3 citations74
US12115192B2Oct 15, 2024
Chimeric antigen receptor compositions and methods for treating MUC1* diseases
MINERVA BIOTECHNOLOGIES CORP3 citations73
US12049514B2Jul 30, 2024
Anti-NME antibody and method of treating cancer or cancer metastasis
MINERVA BIOTECHNOLOGIES CORP3 citations73
US12037413B2Jul 16, 2024
Anti-NME antibody and method of treating cancer or cancer metastasis
MINERVA BIOTECHNOLOGIES CORP3 citations73
US12006371B2Jun 11, 2024
Humanized anti-MUC1* antibodies
MINERVA BIOTECHNOLOGIES CORP3 citations73
US11976295B2May 7, 2024
Media for stem cell proliferation and induction
MINERVA BIOTECHNOLOGIES CORP4 citations73
US11897967B2Feb 13, 2024
Humanized anti-MUC1* antibodies
MINERVA BIOTECHNOLOGIES CORP3 citations73
US10724027B2Jul 28, 2020
Method for making pluripotent stem cells
MINERVA BIOTECHNOLOGIES CORP4 citations73
US10703821B2Jul 7, 2020
Method for stimulating or enhancing proliferation of cells by activating the mucin 1 (MUC1) receptor
MINERVA BIOTECHNOLOGIES CORP5 citations73
US11702483B2Jul 18, 2023
Method of treating an NME7 expressing cancer with a peptide
MINERVA BIOTECHNOLOGIES CORP2 citations72
US11931347B2Mar 19, 2024
Method of screening for agents for differentiating stem cells
MINERVA BIOTECHNOLOGIES CORP5 citations71
US11560435B2Jan 24, 2023
MUC1* antibodies
MINERVA BIOTECHNOLOGIES CORP4 citations70
US12104170B2Oct 1, 2024
Methods for deriving dopaminergic neurons from pluripotent stem cells
MINERVA BIOTECHNOLOGIES CORP2 citations65
US12351646B2Jul 8, 2025
Diagnostic methods using anti-MUC1* antibodies
MINERVA BIOTECHNOLOGIES CORP1 citations64
US12583927B2Mar 24, 2026
Anti-variable MUC1* antibodies and uses thereof
MINERVA BIOTECHNOLOGIES CORP0 citations61
US12479928B2Nov 25, 2025
Anti-cancer peptide
MINERVA BIOTECHNOLOGIES CORP0 citations61
US12202799B2Jan 21, 2025
Agents for differentiating stem cells and treating cancer
MINERVA BIOTECHNOLOGIES CORP2 citations61
US9649312B2May 16, 2017
Compositions and methods of treatment of cancer
MINERVA BIOTECHNOLOGIES CORP0 citations52
US12415868B1Sep 16, 2025
Anti-NME antibody and method of treating cancer or cancer metastasis
MINERVA BIOTECHNOLOGIES CORP0 citations51
US12491259B2Dec 9, 2025
Anti-variable MUC1* antibodies and uses thereof
MINERVA BIOTECHNOLOGIES CORP0 citations46